Hong Kong Pharma Digital Technology Holdings Limited
HKPD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | |
|---|---|---|---|
| Revenue | $20,314 | $16,688 | $12,556 |
| % Growth | 21.7% | 32.9% | – |
| Cost of Goods Sold | $17,899 | $13,130 | $9,817 |
| Gross Profit | $2,415 | $3,559 | $2,739 |
| % Margin | 11.9% | 21.3% | 21.8% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $2,216 | $1,889 | $1,758 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $67 | $61 | -$63 |
| Operating Expenses | $2,283 | $1,950 | $1,695 |
| Operating Income | $132 | $1,608 | $1,044 |
| % Margin | 0.6% | 9.6% | 8.3% |
| Other Income/Exp. Net | -$96 | -$82 | -$23 |
| Pre-Tax Income | $36 | $1,526 | $1,021 |
| Tax Expense | $63 | $196 | $23 |
| Net Income | -$27 | $1,330 | $998 |
| % Margin | -0.1% | 8% | 7.9% |
| EPS | -0.003 | 0.18 | 0.091 |
| % Growth | -101.5% | 98.5% | – |
| EPS Diluted | -0.003 | 0.18 | 0.091 |
| Weighted Avg Shares Out | 9,022 | 7,366 | 11,000 |
| Weighted Avg Shares Out Dil | 10,205 | 7,366 | 11,000 |
| Supplemental Information | – | – | – |
| Interest Income | $2 | $0 | $0 |
| Interest Expense | $98 | $83 | $23 |
| Depreciation & Amortization | $1,073 | $926 | $715 |
| EBITDA | $1,207 | $2,534 | $1,759 |
| % Margin | 5.9% | 15.2% | 14% |